ARCHIVES

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

This article is from The Cancer Letter archive.

Vol. 36 No. 37 | October 15, 2010

Download PDF Visit The Full Archive

Related Articles

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

In Brief: Panel to Meet Jan. 30 In Los Angeles; Fate Of Proposed Urologic Group Depends On Budget

January 10, 1986

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco

January 23, 1998

1981 Budget By Funding Mechanism

June 1, 1979

Salick Signs contract for Fixed-Price Oncology Services

April 1, 1994